Structure Optimization of the Toxic Conformation Model of Amyloid β42 by Intramolecular Disulfide Bond Formation

Chembiochem. 2022 Apr 20;23(8):e202200029. doi: 10.1002/cbic.202200029. Epub 2022 Mar 3.

Abstract

Amyloid β (Aβ) oligomers play a critical role in the pathology of Alzheimer's disease. Recently, we reported that a conformation-restricted Aβ42 with an intramolecular disulfide bond through cysteine residues at positions 17/28 formed stable oligomers with potent cytotoxicity. To further optimize this compound as a toxic conformer model, we synthesized three analogues with a combination of cysteine and homocysteine at positions 17/28. The analogues with Cys-Cys, Cys-homoCys, or homoCys-Cys, but not the homoCys-homoCys analogue, exhibited potent cytotoxicity against SH-SY5Y and THP-1 cells even at 10 nM. In contrast, the cytotoxicity of conformation-restricted analogues at positions 16/29 or 18/27 was significantly weaker than that of wild-type Aβ42. Furthermore, thioflavin-T assay, non-denaturing gel electrophoresis, and morphological studies suggested that the majority of these conformation-restricted analogues exists in an oligomeric state in cell culture medium, indicating that the toxic conformation of Aβ42, rather than the oligomeric state, is essential to induce cytotoxicity.

Keywords: Alzheimer's disease; amyloid-beta; disulfide bonds; oligomers; toxic conformations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / pathology
  • Amyloid / chemistry
  • Amyloid beta-Peptides* / chemistry
  • Amyloid beta-Peptides* / toxicity
  • Cysteine
  • Disulfides / chemistry
  • Humans
  • Peptide Fragments / chemistry
  • Peptide Fragments / toxicity

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • Disulfides
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Cysteine